PITTSFORD, NY--(Marketwire - November 01, 2007) - Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced the composition of the new board of directors of its subsidiary, Myotech. Under the terms of the new deal announced on October 5, in which Biophan now owns 68% of Myotech, a new board of directors has been put in place for the subsidiary with three of the five members appointed by Biophan.
